Investigación / Grupos de investigación

Grupo  602

Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Publicaciones (913)

  • Berrocal, A; Arance, A; Espinosa, E; Castano, AG; Cao, MG; Larriba, JLG; Martin, JAL; Marquez, I; Soria, A; Algarra, SM.

    SEOM guidelines for the management of Malignant Melanoma 2015

    Clinical & Translational Oncology. 2015; 17(12): 1030-1035 Nº de citas: 7 [doi:10.1007/s12094-015-1450-4]

  • Sole, CV; Calvo, FA; Lizarraga, S; Gonzalez-Bayon, L; Segundo, CGS; Desco, M; Garcia-Sabrido, JL.

    Single-Institution Multidisciplinary Management of Locoregional Oligo-Recurrent Pelvic Malignancies: Long-Term Outcome Analysis

    ANNALS OF SURGICAL ONCOLOGY. 2015; 22: 1247-1255 Nº de citas: 4 [doi:10.1245/s10434-015-4604-2]

  • Martin, M; Simon, AR; Borrego, MR; Ribelles, N; Rodriguez-Lescure, A; Munoz-Mateu, M; Gonzalez, S; Vila, MM; Barnadas, A; Ramos, M; Berron, SD; Jara, C; Calvo, L; Martinez-Janez, N; Fernandez, CM; Rodriguez, CA; de Duenas, EM; Andres, R; Plazaola, A; de la Haba-Rodriguez, J; Lopez-Vega, JM; Adrover, E; Ballesteros, AI; Santaballa, A; Sanchez-Rovira, P; Baena-Canada, JM; Casas, M; Camara, MD; Carrasco, EM; Lluch, A.

    Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

    JOURNAL OF CLINICAL ONCOLOGY. 2015; 33(32): 3788 Nº de citas: 68 [doi:10.1200/JCO.2015.61.9510]

  • Climent, MA; Leon-Mateos, L; del Alba, AG; Perez-Valderrama, B; Mendez-Vidal, MJ; Mellado, B; Arranz, JA; Sanchez-Hernandez, A; Cassinello, J; Olmos, D; Carles, J.

    Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer

    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2015; 96(2): 308-318 Nº de citas: 14 [doi:10.1016/j.critrevonc.2015.05.019]

  • Sole, CV; Calvo, FA; Lizarraga, S; Gonzalez-Bayon, L; Garcia-Sabrido, JL.

    Intraoperative electron-beam radiation therapy with or without external-beam radiotherapy in the management of paraaortic lymph-node oligometastases from gynecological malignancies

    Clinical & Translational Oncology. 2015; 17(11): 910-916 Nº de citas: 6 [doi:10.1007/s12094-015-1326-7]

  • Trojan, J; Mineur, L; Tomasek, J; Rouleau, E; Fabian, P; de Maglio, G; Garcia-Alfonso, P; Aprile, G; Taylor, A; Kafatos, G; Downey, G; Terwey, JH; van Krieken, JH.

    Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

    PLoS One. 2015; 10(10): Nº de citas: 10 [doi:10.1371/journal.pone.0140717]

  • Noriega, V; Martinez-Laperche, C; Buces, E; Pion, M; Sanchez-Hernandez, N; Martin-Antonio, B; Guillem, V; Bosch-Vizcaya, A; Bento, L; Gonzalez-Rivera, M; Balsalobre, P; Kwon, M; Serrano, D; Gayoso, J; de la Camara, R; Brunet, S; Rojas-Contreras, R; Nieto, JB; Martinez, C; Gonzalez, M; Espigado, I; Vallejo, JC; Sampol, A; Jimenez-Velasco, A; Urbano-Ispizua, A; Solano, C; Gallardo, D; Diez-Martin, JL; Buno, I.

    The Genotype of the Donor for the (GT)(n) Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation

    PLoS One. 2015; 10(10): Nº de citas: 12 [doi:10.1371/journal.pone.0140454]

  • Casla, S; Lopez-Tarruella, S; Jerez, Y; Marquez-Rodas, I; Galvao, DA; Newton, RU; Cubedo, R; Calvo, I; Sampedro, J; Barakat, R; Martin, M.

    Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial

    BREAST CANCER RESEARCH AND TREATMENT. 2015; 153(2): 371-382 Nº de citas: 99 [doi:10.1007/s10549-015-3541-x]

  • Escobar, Y; Cajaraville, G; Virizuela, JA; Alvarez, R; Munoz, A; Olariaga, O; Tames, MJ; Muros, B; Lecumberri, MJ; Feliu, J; Martinez, P; Adansa, JC; Martinez, MJ; Lopez, R; Blasco, A; Gascon, P; Calvo, V; Luna, P; Montalar, J; Del Barrio, P; Tornamira, MV.

    Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

    SUPPORTIVE CARE IN CANCER. 2015; 23(9): 2833-2840 Nº de citas: 84 [doi:10.1007/s00520-015-2809-3]

  • Giuliano, M; Hu, HZ; Wang, YC; Fu, XY; Nardone, A; Herrera, S; Mao, SF; Contreras, A; Gutierrez, C; Wang, T; Hilsenbeck, SG; De Angelis, C; Wang, NJ; Heiser, LM; Gray, JW; Lopez-Tarruella, S; Pavlick, AC; Trivedi, MV; Chamness, GC; Chang, JC; Osborne, CK; Rimawi, MF; Schiff, R.

    Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

    CLINICAL CANCER RESEARCH. 2015; 21(17): 3995-4003 Nº de citas: 115 [doi:10.1158/1078-0432.CCR-14-2728]

  • Pereira, A; Mendizabal, E; de Leon, J; Perez-Medina, T; Magrina, JF; Magtibay, PM; Rodriguez-Tapia, A; Lizarraga, S; Ortiz-Quintana, L.

    Peritoneal carcinomatosis: A malignant disease with an embryological origin?

    SURGICAL ONCOLOGY-OXFORD. 2015; 24(3): 305-311 Nº de citas: 6 [doi:10.1016/j.suronc.2015.06.002]

  • Carrato, A; Garcia, P; Lopez, R; Macarulla, T; Rivera, F; Sastre, J; Gostkorzewicz, J; Benedit, P; Perez-Alcantara, F.

    Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study

    Expert Review of Pharmacoeconomics & Outcomes Research. 2015; 15(4): 579-589 Nº de citas: 12 [doi:10.1586/14737167.2015.1047349]

  • Cajal, TRY; Chirivella, I; Miranda, J; Teule, A; Izquierdo, A; Balmana, J; Sanchez-Heras, AB; Llort, G; Fisas, D; Lope, V; Hernandez-Agudo, E; Juan-Fita, MJ; Tena, I; Robles, L; Guillen-Ponce, C; Perez-Segura, P; Luque-Molina, MS; Hernando-Polo, S; Salinas, M; Brunet, J; Salas-Trejo, MD; Barnadas, A; Pollan, M.

    Mammographic density and breast cancer in women from high risk families

    BREAST CANCER RESEARCH. 2015; 17: Nº de citas: 24 [doi:10.1186/s13058-015-0604-1]

  • Capdevila, J; Sevilla, I; Alonso, V; Aparicio, LA; Fonseca, PJ; Grande, E; Reina, JJ; Manzano, JL; Lajara, JDA; Barriuso, J; Castellano, D; Medina, J; Lopez, C; Segura, A; Carrera, S; Crespo, G; Fuster, J; Munarriz, J; Alfonso, PG.

    Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis

    BMC CANCER. 2015; 15: Nº de citas: 27 [doi:10.1186/s12885-015-1512-6]

  • Larkin, J; Chiarion-Sileni, V; Gonzalez, R; Grob, JJ; Cowey, CL; Lao, CD; Schadendorf, D; Dummer, R; Smylie, M; Rutkowski, P; Ferrucci, PF; Hill, A; Wagstaff, J; Carlino, MS; Haanen, JB; Maio, M; Marquez-Rodas, I; McArthur, GA; Ascierto, PA; Long, GV; Callahan, MK; Postow, MA; Grossmann, K; Sznol, M; Dreno, B; Bastholt, L; Yang, A; Rollin, LM; Horak, C; Hodi, FS; Wolchok, JD.

    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

    NEW ENGLAND JOURNAL OF MEDICINE. 2015; 373(1): 23-34 Nº de citas: 7216 [doi:10.1056/NEJMoa1504030]

  • Martin, M.

    nab-Paclitaxel dose and schedule in breast cancer

    BREAST CANCER RESEARCH. 2015; 17: Nº de citas: 32 [doi:10.1186/s13058-015-0587-y]

  • Tejera-Alhambra, M; Casrouge, A; de Andres, C; Seyfferth, A; Ramos-Medina, R; Alonso, B; Vega, J; Fernandez-Paredes, L; Albert, ML; Sanchez-Ramon, S.

    Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis

    PLoS One. 2015; 10(6): Nº de citas: 50 [doi:10.1371/journal.pone.0128952]

  • Martin, M; Gonzalez-Rivera, M; Morales, S; de la Haba-Rodriguez, J; Gonzalez-Cortijo, L; Manso, L; Albanell, J; Gonzalez-Martin, A; Gonzalez, S; Arcusa, A; de la Cruz-Merino, L; Rojo, F; Vidal, M; Galvan, P; Aguirre, E; Morales, C; Ferree, S; Pompilio, K; Casas, M; Caballero, R; Goicoechea, U; Carrasco, E; Michalopoulos, S; Hornberger, J; Prat, A.

    Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

    CURRENT MEDICAL RESEARCH AND OPINION. 2015; 31(6): 1129-1137 Nº de citas: 34 [doi:10.1185/03007995.2015.1037730]